Aortyx secures $15.8m for bioresorbable aortic patch
The funding will propel the product towards first-in-human readiness within the next two years.
13 June 2025
13 June 2025
The funding will propel the product towards first-in-human readiness within the next two years.
Innovative cardiac devices are changing how we treat heart defects, offering less invasive, highly targeted options for patients once destined for open-heart surgery.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.